Hepatic arterial infusion chemotherapy combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma with portal vein tumor thrombus: A prospective single-arm study

Zepsun (donafenib) - Suzhou Zelgen

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal_2/print/presentation/2367

Ping Huang; Qiang He; Cheng-rui Wu; Long Pan; Jia-chu Li; Yin Zhou; Zhou-yan Wang; Hong-xiang Cao; Rui-rui Sun; Jun-jie Huang; YongChen Wang; Yang Gou; Zi-xuan Fu; Yao-wu Zhao

Jul 17, 2026